Brought to you by 
IntraPace closes $30mm Series D financing
17 Aug 2006
Executive Summary
IntraPace (implantable devices for obesity) brought in $30mm through an oversubscribed Series D round led by new investor Vulcan Capital. Other first-time backer L Capital Partners was joined by returning shareholders DFJ ePlanet, Oxford Bioscience Partners, Toucan Capital, Guidant, Johnson & Johnson Development Corp., CB Health Ventures, and Halo Fund II (managed by The Angel's Forum). A member of Vulcan Capital and L Capital Partners will take seats on the company's board. IntraPace will use the proceeds for clinical trials of its endoscopic gastric pacemaker.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IntraPace closes $30mm Series D financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice